default author photo

Marwan Abushawish

National Jewish Health

Pionyr Immunotherapeutics

San Francisco, CA 94107

United States

  • Pionyr Immunotherapeutics

SCHOLARLY PAPERS

2

DOWNLOADS

91

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Targeting TREM2 on Tumor Associated Macrophages Enhances Efficacious Immunotherapy

Number of pages: 86 Posted: 16 Feb 2021
Mikhail Binnewies, Marwan Abushawish, Subhadra Dash, Joshua L. Pollack, Joshua Rudolph, Pamela Canaday, Erick Lu, Nadine Jahchan, Manith Norng, Shilpa Mankikar, Tian Lee, Victoria L. Liu, Xiaoyan Du, Amanda Chen, Ranna Mehta, Rachael Palmer, Vladislava Juric, Linda Liang, Leonard Reyno, Matthew F. Krummel, Michel Streuli and Venkataraman Sriram
University of California, San Francisco (UCSF) - Department of Pathology, National Jewish Health, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, Pionyr Immunotherapeutics, University of California, San Francisco (UCSF) - Department of Pathology, Pionyr Immunotherapeutics and Pionyr Immunotherapeutics
Downloads 65 (924,743)

Abstract:

Loading...

2.

NR4A3 Controls an Epigenetic Program that Limits the Fate of Tumor-Specific CD8+ T Cells

Number of pages: 49 Posted: 23 Jan 2026
Marwan Abushawish, Laura Shaw, Angela Prete, Kole R. DeGolier, J SB and Sneak Peek Administrator
National Jewish Health, National Jewish Health, National Jewish Health, National Jewish Health, National Jewish Health and Independent
Downloads 26 (1,411,822)

Abstract:

Loading...

NR4A3, CAR-T cells, TILs, Epigenetics, Histone modifications, Transcription Factors